BMAP-28

General Information


DCTPep ID  DCTPep04662

Peptide Name   BMAP-28

Sequence  GGLRSLGRKILRAWKKYGPIIVPIIRIG

Sequence Length  28

UniProt ID  P54229  B9UKL6  A5PJ96 

PubChem CID  16131512 

Origin  Bos taurus

Type  Native peptide

Classification

  

Cancer therapy related peptides



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available



Structure Information


PDB ID  Not available

Predicted Structure  Not available

(Please note that there is the predicted structure, predicted by AlphaFold)

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Amidation

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C147H252N44O31

Absent amino acids  CDEFHMNQT

Theoretical pI  12.02

Acidic residues  0

Basic residues  7

Polar residues  7

Molecular weight (Average)  3131.89

Molecular weight (Monoisotopic)  3129.95

Common amino acids  I

Net charge  7

Instability index (II)  48.16

Aliphatic index  139.29

Grand average of hydropathicity (GRAVY)  0.232

Half Life 
  30 hours (mammalian reticulocytes, in vitro).
  >20 hours (yeast, in vivo).
  >10 hours (Escherichia coli, in vivo).

Extinction coefficients 
  Ext. coefficient 6990
  Abs 0.1% (=1 g/l) 2.232

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 19735644

Title  Structure-function study of cathelicidin-derived bovine antimicrobial peptide BMAP-28: design of its cell-selective analogs by amino acid substitutions in the heptad repeat sequences

Doi 10.1016/j.bbamem.2009.08.021

Year  2009

Literature 2

Pubmed ID 16997510

Title  Antimicrobial activity of cathelicidins BMAP28, SMAP28, SMAP29, and PMAP23 against Pasteurella multocida is more broad-spectrum than host species specific

Doi 10.1016/j.vetmic.2006.08.005

Year  2006

Literature 3

Pubmed ID 21655347

Title  Effect of BMAP-28 antimicrobial peptides on Leishmania major promastigote and amastigote growth: role of leishmanolysin in parasite survival

Doi 10.1371/journal.pntd.0001141

Year  2011

Literature 4

Pubmed ID 15019203

Title  In vitro and in vivo antimicrobial activity of two alpha-helical cathelicidin peptides and of their synthetic analogs

Doi 10.1016/j.peptides.2003.07.025

Year  2003

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRAMP ID  DRAMP02854

CancerPPD ID  4394

DBAASP ID  7038

DCTPep is developed by Dr.Zheng's team.